ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Abstracts tagged "ankylosing spondylitis (AS) and laboratory tests"

  • Abstract Number: 1531 • ACR/ARHP Annual Meeting 2014

    CUT-Off LEVEL of Adalimumab and Prevalence of Antibodies ANTI-Adalimumab in Patients with Ankylosing Spondylitis: Results from a LOCAL Registry

    Jose Rosas1, Francisca Llinares-Tello2, José M. Senabre-Gallego3, Carlos Santos-Ramirez4, Esteban Salas-Heredia3, Xavier Barber5, Gregorio Santos-Soler3, Juan Molina2, Mario García-Carrasco6, Ana Pons3, Catalina Cano3 and Group Aire-MB3, 1Rheumatology, Hospital Marina Baixa. Villajoyosa, Villajoyosa, Spain, 2Laboratory, Hospital Marina Baixa, Villajoyosa, Spain, 3Rheumatology, Hospital Marina Baixa, Villajoyosa, Spain, 4Rheumatology, Hospital Marina Salud, Denia, Spain, 5Universidad Miguel Hernández, CIO, Elche, Spain, 6Inmunología y Reumatología, Universidad Autónoma de Puebla, Puebla, Mexico

    Background/Purpose To evaluate the Cut-off level of adalimumab (ADL) and the prevalence of antibodies anti-adalimumab (anti-ADL-ab), in patients with psoriatic arthritis (PsA) and ankylosing spondylitis (AS).…

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology